242 related articles for article (PubMed ID: 18627337)
1. Clobetasol propionate emollient formulation foam in the treatment of corticosteroid-responsive dermatoses.
Frangos JE; Kimball AB
Expert Opin Pharmacother; 2008 Aug; 9(11):2001-7. PubMed ID: 18627337
[TBL] [Abstract][Full Text] [Related]
2. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.
Kimball AB; Gold MH; Zib B; Davis MW;
J Am Acad Dermatol; 2008 Sep; 59(3):448-54, 454.e1. PubMed ID: 18539358
[TBL] [Abstract][Full Text] [Related]
3. Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis.
Stein L
J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S39-49. PubMed ID: 15968263
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions.
Gottlieb AB; Ford RO; Spellman MC
J Cutan Med Surg; 2003; 7(3):185-92. PubMed ID: 12704534
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.
Lebwohl M; Sherer D; Washenik K; Krueger GG; Menter A; Koo J; Feldman SR
Int J Dermatol; 2002 May; 41(5):269-74. PubMed ID: 12100701
[TBL] [Abstract][Full Text] [Related]
6. Relative efficacy and interchangeability ofvarious clobetasol propionate vehicles in the management of steroid-responsive dermatoses.
Feldman SR
Curr Ther Res Clin Exp; 2005 May; 66(3):154-71. PubMed ID: 24672120
[TBL] [Abstract][Full Text] [Related]
7. The role of clobetasol propionate emollient 0.05% in the treatment of patients with dry, scaly, corticosteroid-responsive dermatoses.
Gordon ML
Clin Ther; 1998; 20(1):26-39. PubMed ID: 9522102
[TBL] [Abstract][Full Text] [Related]
8. A Review of Topical Corticosteroid Foams.
Payne J; Habet KA; Pona A; Feldman SR
J Drugs Dermatol; 2019 Aug; 18(8):756-770. PubMed ID: 31424707
[TBL] [Abstract][Full Text] [Related]
9. Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis.
Menter A
Cutis; 2012 Feb; 89(2):89-94. PubMed ID: 22474733
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
Tosti A; Iorizzo M; Botta GL; Milani M
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
[TBL] [Abstract][Full Text] [Related]
11. Topical clobetasol propionate in the treatment of psoriasis: a review of newer formulations.
Feldman SR; Yentzer BA
Am J Clin Dermatol; 2009; 10(6):397-406. PubMed ID: 19824740
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind phase 4 study of the efficacy and safety of ethanol-free clobetasol propionate foam, 0.05%, vs vehicle foam in the treatment of chronic hand dermatitis.
Kircik LH; Eastman WJ; Gwazdauskas J
J Drugs Dermatol; 2013 Mar; 12(3):328-34. PubMed ID: 23545917
[TBL] [Abstract][Full Text] [Related]
13. Clobetasol propionate emollient 0.05% in the treatment of atopic dermatitis.
Maloney JM; Morman MR; Stewart DM; Tharp MD; Brown JJ; Rajagopalan R
Int J Dermatol; 1998 Feb; 37(2):142-4. PubMed ID: 9542676
[TBL] [Abstract][Full Text] [Related]
14. Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis.
Mazzotta A; Esposito M; Carboni I; Schipani C; Chimenti S
J Dermatolog Treat; 2007; 18(2):84-7. PubMed ID: 17520464
[TBL] [Abstract][Full Text] [Related]
15. Topical application of natural honey, beeswax and olive oil mixture for atopic dermatitis or psoriasis: partially controlled, single-blinded study.
Al-Waili NS
Complement Ther Med; 2003 Dec; 11(4):226-34. PubMed ID: 15022655
[TBL] [Abstract][Full Text] [Related]
16. Clobetasol propionate--where, when, why?
Pels R; Sterry W; Lademann J
Drugs Today (Barc); 2008 Jul; 44(7):547-57. PubMed ID: 18806904
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis.
Jarratt MT; Clark SD; Savin RC; Swinyer LJ; Safley CF; Brodell RT; Yu K
Cutis; 2006 Nov; 78(5):348-54. PubMed ID: 17186795
[TBL] [Abstract][Full Text] [Related]
18. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
Lebwohl MG; Kircik L; Callis Duffin K; Pariser D; Hooper M; Wenkert D; Thompson EH; Yang J; Kricorian G; Koo J
J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256
[TBL] [Abstract][Full Text] [Related]
19. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.
Jarratt M; Breneman D; Gottlieb AB; Poulin Y; Liu Y; Foley V
J Drugs Dermatol; 2004; 3(4):367-73. PubMed ID: 15303780
[TBL] [Abstract][Full Text] [Related]
20. Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasis.
Menter MA; Caveney SW; Gottschalk RW
J Drugs Dermatol; 2012 Nov; 11(11):1348-54. PubMed ID: 23135087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
